LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

RNA ligase (ATP)

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
RNA ligase (ATP)
Gene product:
mitochondrial RNA ligase 2
Species:
Leishmania donovani
UniProt:
A0A3S5H791_LEIDO
TriTrypDb:
LdBPK_201700.1 , LdCL_200021800 , LDHU3_20.2070
Length:
418

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 22
NetGPI no yes: 0, no: 22
Cellular components
Term Name Level Count
GO:0031019 mitochondrial mRNA editing complex 3 1
GO:0032991 protein-containing complex 1 1
GO:0045293 mRNA editing complex 3 1
GO:0098798 mitochondrial protein-containing complex 2 1
GO:1902494 catalytic complex 2 1

Expansion

Sequence features

A0A3S5H791
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: A0A3S5H791

Function

Biological processes
Term Name Level Count
GO:0006139 nucleobase-containing compound metabolic process 3 1
GO:0006725 cellular aromatic compound metabolic process 3 1
GO:0006807 nitrogen compound metabolic process 2 1
GO:0008152 metabolic process 1 1
GO:0009451 RNA modification 5 1
GO:0009987 cellular process 1 1
GO:0016070 RNA metabolic process 5 1
GO:0034641 cellular nitrogen compound metabolic process 3 1
GO:0043170 macromolecule metabolic process 3 1
GO:0043412 macromolecule modification 4 1
GO:0044237 cellular metabolic process 2 1
GO:0044238 primary metabolic process 2 1
GO:0046483 heterocycle metabolic process 3 1
GO:0071704 organic substance metabolic process 2 1
GO:0090304 nucleic acid metabolic process 4 1
GO:1901360 organic cyclic compound metabolic process 3 1
Molecular functions
Term Name Level Count
GO:0000166 nucleotide binding 3 23
GO:0003824 catalytic activity 1 23
GO:0003972 RNA ligase (ATP) activity 5 23
GO:0005488 binding 1 23
GO:0005524 ATP binding 5 23
GO:0008452 RNA ligase activity 4 23
GO:0016874 ligase activity 2 23
GO:0016886 ligase activity, forming phosphoric ester bonds 3 23
GO:0017076 purine nucleotide binding 4 23
GO:0030554 adenyl nucleotide binding 5 23
GO:0032553 ribonucleotide binding 3 23
GO:0032555 purine ribonucleotide binding 4 23
GO:0032559 adenyl ribonucleotide binding 5 23
GO:0035639 purine ribonucleoside triphosphate binding 4 23
GO:0036094 small molecule binding 2 23
GO:0043167 ion binding 2 23
GO:0043168 anion binding 3 23
GO:0097159 organic cyclic compound binding 2 23
GO:0097367 carbohydrate derivative binding 2 23
GO:0140098 catalytic activity, acting on RNA 3 23
GO:0140640 catalytic activity, acting on a nucleic acid 2 23
GO:1901265 nucleoside phosphate binding 3 23
GO:1901363 heterocyclic compound binding 2 23

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_NRD_NRD_1 12 14 PF00675 0.475
CLV_NRD_NRD_1 141 143 PF00675 0.313
CLV_NRD_NRD_1 179 181 PF00675 0.211
CLV_NRD_NRD_1 255 257 PF00675 0.371
CLV_NRD_NRD_1 283 285 PF00675 0.541
CLV_NRD_NRD_1 296 298 PF00675 0.388
CLV_NRD_NRD_1 3 5 PF00675 0.520
CLV_NRD_NRD_1 38 40 PF00675 0.414
CLV_NRD_NRD_1 385 387 PF00675 0.357
CLV_NRD_NRD_1 397 399 PF00675 0.354
CLV_PCSK_KEX2_1 12 14 PF00082 0.475
CLV_PCSK_KEX2_1 140 142 PF00082 0.374
CLV_PCSK_KEX2_1 179 181 PF00082 0.171
CLV_PCSK_KEX2_1 255 257 PF00082 0.305
CLV_PCSK_KEX2_1 283 285 PF00082 0.564
CLV_PCSK_KEX2_1 296 298 PF00082 0.366
CLV_PCSK_KEX2_1 3 5 PF00082 0.520
CLV_PCSK_KEX2_1 38 40 PF00082 0.400
CLV_PCSK_KEX2_1 385 387 PF00082 0.351
CLV_PCSK_KEX2_1 397 399 PF00082 0.353
CLV_PCSK_KEX2_1 79 81 PF00082 0.276
CLV_PCSK_PC1ET2_1 140 142 PF00082 0.374
CLV_PCSK_PC1ET2_1 79 81 PF00082 0.275
CLV_PCSK_SKI1_1 102 106 PF00082 0.347
CLV_PCSK_SKI1_1 108 112 PF00082 0.238
CLV_PCSK_SKI1_1 152 156 PF00082 0.391
CLV_PCSK_SKI1_1 22 26 PF00082 0.588
CLV_PCSK_SKI1_1 264 268 PF00082 0.349
CLV_PCSK_SKI1_1 320 324 PF00082 0.330
CLV_PCSK_SKI1_1 363 367 PF00082 0.276
CLV_PCSK_SKI1_1 390 394 PF00082 0.283
CLV_PCSK_SKI1_1 4 8 PF00082 0.647
DEG_APCC_DBOX_1 211 219 PF00400 0.369
DEG_APCC_DBOX_1 3 11 PF00400 0.665
DEG_Nend_Nbox_1 1 3 PF02207 0.535
DOC_CKS1_1 378 383 PF01111 0.398
DOC_CYCLIN_RxL_1 1 8 PF00134 0.445
DOC_CYCLIN_RxL_1 102 113 PF00134 0.411
DOC_CYCLIN_RxL_1 9 21 PF00134 0.370
DOC_MAPK_gen_1 140 147 PF00069 0.294
DOC_MAPK_gen_1 296 302 PF00069 0.473
DOC_MAPK_gen_1 9 18 PF00069 0.553
DOC_PP1_RVXF_1 388 395 PF00149 0.373
DOC_USP7_MATH_1 78 82 PF00917 0.311
DOC_USP7_MATH_2 346 352 PF00917 0.264
DOC_USP7_UBL2_3 363 367 PF12436 0.274
DOC_WW_Pin1_4 115 120 PF00397 0.369
DOC_WW_Pin1_4 350 355 PF00397 0.294
DOC_WW_Pin1_4 377 382 PF00397 0.372
LIG_14-3-3_CanoR_1 12 16 PF00244 0.544
LIG_14-3-3_CanoR_1 179 186 PF00244 0.264
LIG_14-3-3_CanoR_1 320 327 PF00244 0.407
LIG_14-3-3_CanoR_1 334 339 PF00244 0.315
LIG_APCC_ABBA_1 15 20 PF00400 0.409
LIG_BIR_III_4 262 266 PF00653 0.231
LIG_FHA_1 110 116 PF00498 0.317
LIG_FHA_1 119 125 PF00498 0.294
LIG_FHA_1 321 327 PF00498 0.392
LIG_FHA_1 378 384 PF00498 0.402
LIG_FHA_1 54 60 PF00498 0.278
LIG_FHA_1 6 12 PF00498 0.571
LIG_FHA_2 179 185 PF00498 0.373
LIG_FHA_2 351 357 PF00498 0.304
LIG_LIR_Gen_1 183 194 PF02991 0.267
LIG_LIR_Gen_1 27 35 PF02991 0.363
LIG_LIR_Gen_1 274 282 PF02991 0.452
LIG_LIR_LC3C_4 247 251 PF02991 0.278
LIG_LIR_Nem_3 168 174 PF02991 0.303
LIG_LIR_Nem_3 23 29 PF02991 0.403
LIG_LIR_Nem_3 274 279 PF02991 0.421
LIG_LIR_Nem_3 402 407 PF02991 0.410
LIG_LIR_Nem_3 88 93 PF02991 0.280
LIG_NRBOX 356 362 PF00104 0.265
LIG_Pex14_2 49 53 PF04695 0.294
LIG_PTB_Apo_2 156 163 PF02174 0.364
LIG_SH2_CRK 93 97 PF00017 0.281
LIG_SH2_NCK_1 133 137 PF00017 0.278
LIG_SH2_NCK_1 29 33 PF00017 0.413
LIG_SH2_SRC 133 136 PF00017 0.294
LIG_SH2_STAP1 172 176 PF00017 0.278
LIG_SH2_STAP1 191 195 PF00017 0.120
LIG_SH2_STAP1 206 210 PF00017 0.154
LIG_SH2_STAP1 87 91 PF00017 0.213
LIG_SH2_STAT3 103 106 PF00017 0.396
LIG_SH2_STAT5 103 106 PF00017 0.162
LIG_SH2_STAT5 165 168 PF00017 0.437
LIG_SH2_STAT5 186 189 PF00017 0.354
LIG_SH2_STAT5 391 394 PF00017 0.333
LIG_SH2_STAT5 399 402 PF00017 0.365
LIG_SH3_1 133 139 PF00018 0.288
LIG_SH3_2 136 141 PF14604 0.411
LIG_SH3_3 133 139 PF00018 0.288
LIG_SH3_3 302 308 PF00018 0.408
LIG_SH3_3 375 381 PF00018 0.271
LIG_TRAF2_1 181 184 PF00917 0.411
LIG_TRAF2_1 275 278 PF00917 0.402
LIG_TRAF2_1 291 294 PF00917 0.361
LIG_UBA3_1 96 105 PF00899 0.444
MOD_CK1_1 118 124 PF00069 0.371
MOD_CK1_1 337 343 PF00069 0.369
MOD_CK2_1 178 184 PF00069 0.314
MOD_CK2_1 27 33 PF00069 0.472
MOD_CK2_1 350 356 PF00069 0.417
MOD_GlcNHglycan 201 204 PF01048 0.231
MOD_GlcNHglycan 302 305 PF01048 0.405
MOD_GlcNHglycan 80 83 PF01048 0.285
MOD_GSK3_1 296 303 PF00069 0.406
MOD_GSK3_1 337 344 PF00069 0.257
MOD_GSK3_1 346 353 PF00069 0.229
MOD_NEK2_1 226 231 PF00069 0.278
MOD_NEK2_1 271 276 PF00069 0.358
MOD_PIKK_1 346 352 PF00454 0.368
MOD_PK_1 296 302 PF00069 0.399
MOD_PK_1 334 340 PF00069 0.369
MOD_PKA_1 296 302 PF00069 0.408
MOD_PKA_2 11 17 PF00069 0.539
MOD_PKA_2 178 184 PF00069 0.264
MOD_PKA_2 27 33 PF00069 0.383
MOD_PKA_2 296 302 PF00069 0.390
MOD_PKB_1 150 158 PF00069 0.264
MOD_Plk_1 355 361 PF00069 0.325
MOD_Plk_2-3 27 33 PF00069 0.406
MOD_Plk_4 118 124 PF00069 0.294
MOD_Plk_4 264 270 PF00069 0.294
MOD_Plk_4 309 315 PF00069 0.382
MOD_Plk_4 334 340 PF00069 0.369
MOD_Plk_4 356 362 PF00069 0.255
MOD_ProDKin_1 115 121 PF00069 0.369
MOD_ProDKin_1 350 356 PF00069 0.294
MOD_ProDKin_1 377 383 PF00069 0.368
MOD_SUMO_rev_2 14 24 PF00179 0.412
MOD_SUMO_rev_2 258 266 PF00179 0.422
MOD_SUMO_rev_2 368 378 PF00179 0.411
TRG_DiLeu_BaEn_1 356 361 PF01217 0.437
TRG_DiLeu_BaLyEn_6 378 383 PF01217 0.487
TRG_ENDOCYTIC_2 186 189 PF00928 0.262
TRG_ENDOCYTIC_2 29 32 PF00928 0.363
TRG_ENDOCYTIC_2 391 394 PF00928 0.315
TRG_ENDOCYTIC_2 87 90 PF00928 0.292
TRG_ENDOCYTIC_2 93 96 PF00928 0.272
TRG_ER_diArg_1 11 13 PF00400 0.487
TRG_ER_diArg_1 178 180 PF00400 0.171
TRG_ER_diArg_1 2 4 PF00400 0.528
TRG_ER_diArg_1 295 297 PF00400 0.369
TRG_ER_diArg_1 38 40 PF00400 0.416
TRG_ER_diArg_1 384 386 PF00400 0.442
TRG_ER_diArg_1 397 399 PF00400 0.312
TRG_NLS_MonoExtN_4 139 144 PF00514 0.430
TRG_Pf-PMV_PEXEL_1 108 113 PF00026 0.375

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N1HTX0 Leptomonas seymouri 76% 100%
A0A0N1IKD9 Leptomonas seymouri 42% 81%
A0A0S4IH84 Bodo saltans 40% 85%
A0A0S4JRM1 Bodo saltans 57% 82%
A0A1X0NW43 Trypanosomatidae 69% 100%
A0A1X0P2V9 Trypanosomatidae 41% 90%
A0A3R7NWI2 Trypanosoma rangeli 70% 100%
A0A422NFE4 Trypanosoma rangeli 42% 91%
A0A451EJB4 Leishmania donovani 39% 99%
A4H382 Leishmania braziliensis 39% 100%
A4HRI2 Leishmania infantum 39% 100%
A4HZ02 Leishmania infantum 100% 100%
C9ZIM1 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 66% 100%
C9ZXL1 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 41% 89%
E9AC50 Leishmania major 39% 100%
E9AIM1 Leishmania braziliensis 89% 100%
E9AJE6 Leishmania mexicana (strain MHOM/GT/2001/U1103) 38% 100%
E9AUV4 Leishmania mexicana (strain MHOM/GT/2001/U1103) 97% 100%
P32277 Enterobacteria phage T4 25% 100%
P86924 Trypanosoma brucei brucei 66% 100%
P86925 Trypanosoma brucei brucei (strain 927/4 GUTat10.1) 66% 100%
P86926 Trypanosoma brucei brucei 41% 89%
P86927 Trypanosoma brucei brucei (strain 927/4 GUTat10.1) 41% 89%
Q6T452 Leishmania major 96% 100%
V5ASZ3 Trypanosoma cruzi 69% 100%
V5DD75 Trypanosoma cruzi 42% 84%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS